PPTA Europe’s Post

We have just launched our International Plasma Awareness Week website at www.plasmaweek.org. Here, you’ll find all the information you need to get involved in #IPAW2024. Be sure to download visuals that will brighten up your social media feeds with vibrant colors and important messages all week long! Takeda Grifols Kedrion Biopharma #PlasmaIsUnique, #PlasmaDonorsSaveLives #ThankYouPlasmaDonors  #EUNeedsMorePlasma 

People are born every day with plasma protein deficiencies. 👇 These deficiencies occur when the body either lacks certain essential proteins found in blood plasma or has dysfunctional proteins, often due to genetic factors or other underlying conditions. These proteins are vital because they help the immune system fight off infections, ensure that the blood clots properly to stop bleeding, and keep the body healthy overall. If these proteins are missing, inadequate or not working properly, this can lead to serious health problems such as: ➡ Immune deficiencies ➡ Bleeding disorders ➡ Neurological conditions ➡ Inflammatory diseases ➡ Other serious conditions ♻ Share this post to raise awareness. 

Registration is now open for the 2024 PPTA Plasma Protein Forum "Taking Steps Toward a Better Tomorrow." The premiere event will be held November 19-20 at the Washington Marriott Georgetown in Washington, D.C. Visit https://lnkd.in/eDJ2xWRY to learn more and register today.

✉️ Writing to a Member of the European Parliament (MEP) is a powerful way to make your voice heard. Whether you’re a patient, advocate, or health care professional, your letter can bring attention to the challenges faced by patients. Use this #IPAW2024 template to send a thoughtful letter to an MEP and help drive necessary policy conversations. Get started here: https://lnkd.in/emyfbqrc #PlasmaIsUnique #PlasmaDonorsSaveLives #ThankYouPlasmaDonors #EUNeedsMorePlasma

Donating plasma saves lives. Each time a donor walks into a collection center and rolls up their sleeve, they make a significant impact. Discover real patient stories that highlight the life-changing effects of plasma-derived medicines (PDMPs) at https://lnkd.in/eDUisCGn Brenda, who lives with multifocal motor neuropathy (MMN), shares her experience: “It gave me back everything. It gave me back hope. Plasma is the only treatment that works. There is no other treatment option—this is it; this is all we’ve got”.

Curious about the men and women who have made significant contributions to the plasma protein therapeutic field? Here are 5 notable figures: 📌 Professor Edward Cohn pioneered what was then the first practical, large-scale method of blood plasma fractionation. 📌 Dr. Josep Antoni Grífols-Lucas conducted the first systematic study of the application of plasmapheresis. 📌 Dr. Charles Drew work was instrumental in developing a method for safely collecting, processing and storing large amounts of contamination-free plasma. 📌 Dr. Judith Pool discovery of cryoprecipitate in the 1960s was a breakthrough in the treatment of haemophilia.  📌 Dr. Carl-Bertil Laurell discovered that an inherited lack of Alpha 1-antitrypsin could lead to emphysema. The plasma protein therapeutics industry is deeply rooted in scientific research and technological advancement. PPTA member companies follow the science to drive innovation and ensure the highest standards for donors and patients. https://lnkd.in/edf2Rbwp Kedrion Biopharma Takeda Grifols

Did you know that plasma can be transfused directly into a patient? This often happens in emergency situations and can be lifesaving for patients undergoing treatment for trauma, burn, shock, or other severe medical situations. Direct transfusion of this plasma is especially crucial in emergency situations where rapid blood volume replacement is essential for patient survival. Learn more about the everyday uses of plasma at https://lnkd.in/eHfAN6nM

PPTA unites companies from around the world and across the plasma therapeutics sector. All working towards a future where every patient has uninterrupted access to life-saving plasma-derived medicinal products (PDMPs). Our industry is committed to scientific excellence, creating hundreds of thousands of jobs, and advancing global health through the groundbreaking work of leading scientists. With supportive policies and better regulatory frameworks, we can reach even more patients worldwide.  ➡ https://lnkd.in/e2Tx7SWD #Foreverypatient #everyday #EUNeedsMorePlasma #PlasmaDonorsSaveLives

⚡Plasma 101: Why is the clinical need for plasma-derived medicines increasing worldwide? Let's break down some of the factors.    1. Increased precision of medical diagnostics.  2. More people are being identified with rare conditions.   3. Emerging clinical evidence show the benefits of PDMPs.  4. Greater awareness helps early diagnosis of rare conditions.  5. Patients live longer and healthier lives than ever before.  6. Medical research finds new applications for PDMPs    To keep up with the growing clinical need for plasma-derived medicines, EU countries should consider adopting best practices from Austria, Czechia, Germany, and Hungary. These countries have shown how the public-private coexistence model can work to boost plasma availability for producing plasma-derived medicines.     It’s a proven approach that could really benefit us all!    #EUNeedsMorePlasma   #TheWorldNeedsMorePlasma